NCT03305445
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
Clinical trial condition
Lymphoma, B-Cell
Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.
1,618 public trials
340 recruiting studies
Lymphoma, B-Cell trial results
NCT00002663
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +44 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02257242
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
- Locations
-
- Rhode Island Hospital and The Miriam Hospital Providence, Rhode Island, United States
NCT03357627
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Emory University Atlanta, Georgia, United States
- NorthShore Medical Group - Evanston Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
NCT02555267
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Chonbuk National University Hospital Jeonju, South Korea
NCT03211702
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Chonnam National University Hwasun Hospital Hwasun, South Korea
- Chonbuk National University Hospital Jeonju, South Korea
NCT04859920
- Conditions
- Diffuse Large Cell Diffuse Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Chu Dijon Bourogne Dijon, France
NCT02853370
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Créteil (Hôpital Henri Mondor) Créteil, France
- Dijon (CHU de Dijon - Hôpital d'Enfants) Dijon, France
- Grenoble cedex 9 (CHU Michallon) Grenoble, France
- Le Kremlin Bicêtre (Hôpital Bicêtre) Le Kremlin-Bicêtre, France
NCT03049449
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Completed
Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas
NCT03276468
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- CHU d'Angers Angers, France
- CHU de Caen Caen, France
- CHU de Clermont Ferrand - Estaing Clermont-Ferrand, France
- Hopital Henri Mondor Créteil, France